Sana Biotechnology (SANA)
(Delayed Data from NSDQ)
$1.65 USD
+0.05 (3.13%)
Updated Dec 20, 2024 04:00 PM ET
After-Market: $1.67 +0.02 (1.21%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Sana Biotechnology (SANA) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$11.83 | $16.00 | $8.00 | 639.38% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for Sana Biotechnology comes to $11.83. The forecasts range from a low of $8.00 to a high of $16.00. The average price target represents an increase of 639.38% from the last closing price of $1.60.
Analyst Price Targets (6 )
Find the top stocks with the greatest price target potential and Zacks Rank of 1 or 2
Broker Rating
Sana Biotechnology currently has an average brokerage recommendation (ABR) of 1.75 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 1.75 a month ago based on eight recommendations.
Of the eight recommendations deriving the current ABR, five are Strong Buy, representing 62.5% of all recommendations. A month ago, Strong Buy represented 62.5%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 6 | 5 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 3 | 3 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.75 | 1.75 | 1.75 | 1.50 | 1.57 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
11/11/2024 | Cowen & Co. | Marc Frahm | Hold | Hold |
11/11/2024 | H.C. Wainwright & Co. | Emily Bodnar | Strong Buy | Strong Buy |
11/5/2024 | JMP Securities | Reni Benjamin | Strong Buy | Hold |
6/26/2024 | Rodman & RenshawCo. | Tony Butler | Not Available | Strong Buy |
6/1/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.75 |
ABR (Last week) | 1.75 |
# of Recs in ABR | 8 |
Average Target Price | $11.83 |
LT Growth Rate | 17.50% |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 65 of 251 |
Current Quarter EPS Est: | -0.25 |
SANA FAQs
Sana Biotechnology, Inc. (SANA) currently has an average brokerage recommendation (ABR) of 1.75 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 8 brokerage firms.
The average price target for Sana Biotechnology, Inc. (SANA) is $11.83. The current on short-term price targets is based on 4 reports.
The forecasts for Sana Biotechnology, Inc. (SANA) range from a low of $8 to a high of $16. The average price target represents a increase of $616.97 from the last closing price of $1.65.
The current UPSIDE for Sana Biotechnology, Inc. (SANA) is 616.97%
Based on short-term price targets offered by six analysts, the average price target for Sana Biotechnology comes to $11.83. The forecasts range from a low of $8.00 to a high of $16.00. The average price target represents an increase of 639.38% from the last closing price of $1.60.